NCT00003957View on ClinicalTrials.gov

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 1998

Primary Completion Date

September 30, 2000

Study Completion Date

August 31, 2001

Conditions

Lymphoma

Interventions

BIOLOGICAL

filgrastim

BIOLOGICAL

recombinant human stem cell factor

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

etoposide

DRUG

melphalan

DRUG

mitoxantrone hydrochloride

DRUG

paclitaxel

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

19111

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Fox Chase Cancer Center

OTHER

NCT00003957 - Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter